Food and Drug Administration approves Janssen Pharmaceutica's esketamine for treatment-resistant depression. The drug is the chemical cousin of ketamine, a powerful anesthetic and recreational drug, and the first major new depression treatment to be approved by the FDA in more than 30 years.
The US Food and Drug Administration approved Janssen Pharmaceuticals Inc.'s esketamine on Tuesday for treatment-resistant depression; the drug is the chemical cousin of ketamine, the powerful anesthetic that has been used illegally as the club drug Special K.
FDA approves nasal spray for depression © CNN
the Context. Made in Cyberspace. Learn more...
This page is distributed under CC BY-SA 3.0 and available in many open API formats: Markdown, HTML, JSON and XML.
Document history via GitHub. Push nofitications via Twitter.
Original news text authored by contributors of
Wikipedia® Current Events Portal is available under CC BY-SA 3.0; additional terms may apply. Open graph meta tags contents: titles, descriptions and images delivered by the news sources are explicitly public and their display constitutes fair use, however each item may contain registered trademarks of third parties and/or specific limitations on reuse; additional terms may apply. Names of the news sources are registered trademarks of respective media organisations.
By using this site, you agree to the